T he INTERSTROKE investigators from 32 countries in Asia, the Americas, Europe, Australia, the Middle East, and Africa conducted a case-control study of patients suffering acute stroke compared with controls. Researchers compared 13,447 acute stroke cases (10, 388 with ischemic stroke and 3,059 with hemorrhagic stroke) with 13,472 matched controls. The investigators identified 10 modifiable risk factors that may have prevented 90.7% of strokes.
The most important modifiable risk factor is hypertension. Eliminating high blood pressure would reduce stroke risk by 48%. There were regional variations, with hypertension causing about 39% of strokes in North America, Australia, and Western Europe, and nearly 60% of strokes in Southeast Asia. The other modifiable risk factors, with obvious overlap in many patients are:
z Physical inactivity: 36% 
Commentary
Stroke is the third leading cause of death and a major cause of disability, and as this study shows is highly preventable. Unhealthy lifestyle leads to more than 90% of all strokes worldwide. The same could be said of heart disease and many cancers. Most instances of poor health and premature demise are self-inflicted.
An argument can be made about personal responsibility in avoiding preventable chronic illness and events such as stroke. Individuals are in charge of their own lifestyle decisions. However, one also can make an argument that these risk factors are a public health problem, with culture and environment leading to poor health choices. In his book Fat Chance, Robert Lustig from the University of California, San Francisco makes this argument forcefully.1 Lustig points to the ill effects of added sugars and high fructose corn syrup leading to obesity, type 2 diabetes, metabolic syndrome, and fatty liver, with the food industry largely to blame by hooking the population on these addictive sweets. The public health response has been lukewarm at best.
Science is coming together with medical practice to put more focus on modifiable risk factors in chronic disease and preventing major events such as stroke. Had this study been conducted 20 years ago, smoking would have been a much greater factor. We have the resources to become much healthier worldwide by adopting healthy lifestyles and protecting the environment. The public is becoming better educated in this area, and those businesses that sell unhealthy products are beginning to feel the effect. Physicians, especially those in primary care, should be "captains" in the battle against the poor health choices that surround us every day.
S
troke is a common problem, affecting nearly 800,000 people annually in the United States.
1 Domestically, it is the fifth most common cause of death and a leading cause of significant long-term disability.
1 Stroke costs the United States an estimated $34 billion each year.
1 Given this extraordinary burden on the health of the American population, appropriate stroke prevention measures could dramatically improve our quality and length of life.
The widespread institution of screening, risk factor modification, and treatment of known cardiac and cerebrovascular disease is paramount to the health of our nation. The following article discusses the best evidence-based practice for stroke diagnosis, prevention, and risk factor management. Where strong data are absent, usual practice and expert consensus are accepted and noted as such.
Stroke Epidemiology
There are nearly 800,000 strokes in the United States each year, with 130,000 associated deaths.
1,2 Although stroke is the second leading cause of death worldwide, it is only the fifth most likely cause in the United States.
1,2 Because of the major disability associated with stroke, the overall cost to this country is substantial. Up to 30% of patients who survive a stroke will require institutional care. 2 Mortality from stroke varies according to ethnicity, with blacks twice as likely to suffer a stroke and more likely to die compared to whites. 2 The "stroke belt" in the southeastern United States has the highest national stroke mortality. 2 Stroke risk increases with age, but 34% of stroke affects individuals younger than 65 years of age. 2 The overall stroke incidence is expected to rise in the near future as the population ages, despite recent advances in risk factor reduction, which has reduced the per capita incidence of strokes. There are gender differences in stroke rates as well.Women are 50% more likely than men to have a stroke, particularly due to a high incidence in white elderly females. 2 
Modifiable Stroke Risk Factors
Hypertension is the most important modifiable stroke risk factor. Multiple trials have shown the benefit of blood pressure control, including many different agents such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, and diuretics. 3 The choice of agent is less crucial than the successful lowering of blood pressure. In general, blood pressure treatment should be targeted to a normal blood pressure of < 140/90 mmHg. 3 However, recent evidence suggests a more aggressive goal of systolic < 120 mmHg may be beneficial for the primary prevention of cardiovascular events. 4 Although these data applied to a composite outcome of stroke, myocardial infarction, heart failure, and vascular death, they confirm that "pre-hypertension" (diastolic 80-90 and systolic 120-140) contributes to increased stroke risk.
Hypercholesterolemia is another important stroke risk factor. Low-density liporprotein (LDL) cholesterol in patients with a prior stroke should be < 70 mg/dL. Cholesterol lowering is particularly important in patients with a prior history of atherosclerotic disease, in which case the American Heart Association (AHA) recommends titrating statins to the maximum tolerated dosage (high-intensity statin) rather than specific LDL goals. 5 Large cohorts of patients with prior myocardial infarction, such as the Heart Protection Study, have shown that control of lipids not only prevents future heart attack but specifically lowers stroke rates by about 25%. 6 Obstructive sleep apnea (OSA) approximately doubles the risk of stroke when compared to controls, and stroke rates increase steadily with OSA severity. 7 The mechanism by which OSA results in cerebral embolism is not entirely certain; however, it is known that sleep-disordered breathing increases the development of atrial fibrillation, a potent stroke risk factor. 8 The treatment for OSA is quite effective. Continuous positive airway pressure (CPAP) therapy has been shown to be effective in reducing stroke risk to equal patients with no history of sleep-disordered breathing. 7 Diabetes is known to confer excess risk of stroke independent of blood pressure. 9 Specific stroke mechanisms, such as large artery atherosclerotic disease or small vessel ischemia, are associated with poor glucose control. 9 Despite stroke being a known vascular complication of diabetes, mimic stroke include seizure with postictal deficits, migraine aura, conversion disorder, encephalopathy from metabolic disturbances, intracranial tumors or infections, hypertensive encephalopathy, Bell's palsy, transient global amnesia, spinal or nerve disorders, peripheral vertigo, and syncope. The discrimination of a true vascular event from a mimic is important in terms of treatment and follow-up. Whereas TIA is a known risk factor for subsequent stroke, the risk of future vascular events after the diagnosis of a mimic is negligible. 23, 24 The ABCD2 score may be helpful in making the diagnosis of a non-vascular event. Lower scores on this scale are associated with mimics, rather than true TIAs, and have a low likelihood of future stroke. 24 Nevertheless, this differentiation between mimic and true stroke may not be as important in the acute setting, since it has been deemed safe to treat mimics with intravenous (IV) tissue plasminogen activator. The risk of symptomatic intracranial hemorrhage following IV thrombolysis has been demonstrated to be 1% or less.
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Stroke Mechanisms
Causes of Stroke. Ischemic stroke, the damage to neuronal tissue as a result of reduced cerebral blood flow, can be a common endpoint due to many conditions. The main causes of stroke are due to either thrombosis or embolism of a cerebral artery. Thrombosis refers to a local occlusive process formed in situ within the artery. The site of obstruction may occur either within a large intra-or extracranial artery (which is typically the result of atherosclerosis) or within a small penetrating artery (which typically is due to chronic vessel changes from hypertension). 26, 27 On the other hand, embolism refers to thrombus that travels from the site of formation and lodges within distal vessels. The source of embolism either may be a proximal artery, the heart, or paradoxically from the venous system in the case of a patent foramen ovale (PFO). 26, 27 Embolic strokes tend to cause symptoms that are abrupt and maximal at onset. 26 Additionally, embolism often leads to cortical infarction in the cerebral surface of an arterial territory and is more likely to be associated with hemorrhagic conversion.
28
TOAST Classification System. There have been many attempts to categorize mechanisms of stroke for clinical and research purposes. A commonly used classification schema for stroke subtype is known as the TOAST system.
27
(See Table 2 .) The TOAST system has inherent limitations, namely the large number of stroke patients who resultantly are classified as cryptogenic (i.e., having undetermined etiology). The TOAST investigators did not require aggressive diagnostic testing, by today's standards, prior to categorizing a patient as cryptogenic; for instance, transesophageal echocardiogram and extended arrhythmia monitoring were not required. Nevertheless, it is a useful tool for research purposes and for conceptualizing stroke mechanism in a simplified manner.
Lacunar Stroke. Lacunar stroke refers to the pathophysiological, clinical, and radiographic findings observed in small vessel disease. A lacunar stroke is the result of arterial obstruction of a single deep, penetrating vessel that supplies the subcortical structures of the brain, such as the capsule, basal ganglia, thalamus, and paramedian brainstem.
26,29
Such arterial obstruction is associated with the pathological changes occurring in response to chronic hypertension or diabetes, including microatheroma or lipohyalinosis.
26 Lipohyalinosis refers to the degenerative change in small blood vessels due to the accumulation of lipid within the vessel wall.
26
Since the affected arteries are small, the resultant strokes (known as lacunes) also are small. These irregular cavitary lesions typically are < 1.5 centimeters in diameter. 30 Radiographically, lacunar strokes appear as small infarcts in typical subcortical structures, with MRI being more sensitive than CT for detecting these lesions. 26 (See Figure 1 .) The imaging findings of a small, deep infarct in the absence of other possible stroke etiologies is strongly supportive of a lacunar etiology. Larger areas of infarction, known as giant or super lacunes, may imply thrombosis or embolism of the proximal branch from which the penetrating artery arises; for instance, a lenticulostriate territory stroke could result from a nonocclusive embolus to the middle cerebral artery. 26 Therefore, subcortical strokes > 1.5 centimeters in size may necessitate a diagnostic evaluation aimed at finding an embolic source of stroke, including echocardiography, telemetry, and noninvasive angiography of the head and neck.
Lacunar infarcts clinically present as one of several classic syndromes, with the following being the most common: pure motor weakness, pure sensory loss, mixed sensorimotor, ataxia hemiparesis, and dysarthria-clumsy hand syndromes. 31 The symptoms of lacunar stroke often fluctuate over the acute course of the disease, hence the name "stut- tering lacune." Although lacunar strokes comprise nearly 20% of strokes, 32 they have the lowest in-hospital mortality of the subtypes.
33
Cardioembolic Stroke. Cerebral embolism occurs when particulate material from a proximal source travels through the arterial system to lodge within a downstream cerebral artery. Emboli to the brain are most often composed of mural thrombi or platelet aggregates and most often travel to the anterior circulation (particularly the middle cerebral artery territory), given that these arteries accept the majority of cerebral blood flow. 26 Although an embolic etiology accounts for up to 70% of stroke cases, 26 probable or definite evidence of cardiac embolism is demonstrated in only 25-30% of ischemic strokes. 32 In other instances, the source of embolus may be a proximal large artery, the venous circulation in the case of a PFO, or unknown (cryptogenic). 27 A cardiac source is implied if the emboli result in bilateral infarcts, particularly if cortical and in multiple vascular territories. 28 (See Figure 2. ) For example, a potential cardioembolic etiology of stroke would be inferred from an MRI demonstrating simultaneously occurring left middle cerebral artery and right posterior cerebral artery acute transcortical infarctions. These emboli tend to be evanescent, and obstruction of an intracranial artery may recanalize spontaneously, 34 likely contributing to the higher rate of intracerebral hemorrhage with reperfusion associated with embolic strokes.
28
There are many potential causes of cerebral cardioembolism. (See Table 3 .) Whether a stroke can be attributed to a cardioembolic source requires the identification of a known cardiac risk factor for embolic stroke, as well as the exclusion of other etiologies, such as large artery atherosclerosis or lacunar infarct, based on dedicated neuroimaging. 27 The probability of a stroke being attributed to an identified cardiac risk factor depends on how strongly that risk factor is associated with ischemic stroke. 27 The most common high-risk sources of cardioembolism include valvular heart disease, the formation of an intracardiac thrombus (e.g., recent myocardial infarction or atrial fibrillation), ventricular or septal aneurysms, and cardiomyopathies. Three specific cardiac sources of stroke, including atrial fibrillation, PFO, and aortic arch atheroma, are discussed in depth below.
Atrial Fibrillation as a Stroke Risk Factor. Atrial fibrillation is the most common sustained cardiac arrhythmia, occurring in 1-2% of the general population, and is even more prevalent in aging populations. 35 Atrial fibrillation can lead to left atrial or atrial appendage thrombus formation, which can serve as a source of embolism. The arrhythmia is a very strong risk factor for stroke, increasing this risk by as A B monitoring on cardioembolic stroke recurrence due to the known superiority of anticoagulation to antiplatelets in medium-to high-risk atrial fibrillation patients. However, this has yet to be proven definitively. In the meantime, a standard approach is to monitor cryptogenic stroke patients for at least 30 days, while treating them with antiplatelet therapy, unless atrial fibrillation is discovered.
107
In addition to extended arrhythmia monitoring, it has been suggested that additional advanced diagnostic techniques be used to uncover other potential stroke etiologies in cryptogenic patients who have otherwise unremarkable routine stroke evaluations. 60 Such testing could include the measurement of D-dimer and screening for occult malignancy to rule out cancer-related coagulopathy. Aortic pathology such as atherosclerosis also may embolize to the brain and is best visualized using transesophageal echocardiography. Interatrial shunts, including PFO and atrial septal defects, should be tested for with bubble studies either using echocardiography or transcranial Doppler. Advanced, high-resolution vascular wall imaging, with or without contrast, also may detect arterial plaques with ulceration or other high-risk elements that could serve as a source of embolism.
Conclusion
Given the frequency of stroke occurrence, and the high rates of resultant death and disability, an evidence-based prevention strategy is one of the largest weapons in a clinican's armamentarium against stroke. With time, we are learning more about the importance of precise risk factor management, the role of statins for atherosclerotic disease, and the use of targeted antithrombotic therapy based on the underlying mechanism of stroke. Whereas large artery atherosclerotic and small vessel disease responds to antiplatelet agents, anticoagulation has been found to be superior in certain high-risk cardiac conditions, such as atrial fibrillation. The recent expansion of oral anticoagulants to include factor Xa and direct thrombin inhibitors has significantly improved the overall risk/benefit profile of the medical therapy for patients with nonvalvular atrial fibrillation. Surgical options also vary by stroke subtype and mechanism. Although symptomatic cervical carotid stenosis is amenable to revascularization with stenting or endarterectomy, stenting of intracranial atherosclerosis has proven harmful in clinical trials. Patients with unexplained stroke after a standard diagnostic evaluation, particularly if young, should have advanced testing to evaluate for rarer causes of stroke. If a cryptogenic stroke appears embolic on neuroimaging, such patients may benefit from extended cardiac monitoring or empiric anticoagulation, although randomized trial data are needed to demonstrate improved clinical outcomes with such practice. 
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veryone knows that shortening the time to treatment is key to improving outcomes in stroke patients. However, some experts believe that continued progress in this area requires a bold approach and new thinking on how care can be delivered optimally. For example, a number of medical centers are experimenting with the use of mobile stroke units (MSU), ambulance-like vehicles that are equipped with the necessary technology and expertise to bring brain-saving treatment to the patient.
Although the units are deployed in several states, including Texas, Ohio, Colorado, Tennessee, and New York, investigators at these pioneering sites are experimenting with all the different parameters, everything from how, when, and where the units should be deployed to how the MSUs should interface ideally with hospitals and EDs. Further, some sites are experimenting with larger, more robust units equipped with the technology to perform more sophisticated diagnostics and potentially more care delivery in the prehospital environment.
Cut Through Red Tape
In October 2016, New York Presbyterian/Weill Cornell Medical Center in New York became the first medical center on the East Coast to deploy an MSU. It's a project that Matthew Fink, MD, the neurologist-in-chief of the Division of Stroke and Critical Care Neurology at the hospital, has been championing since 2013.
"The very first ambulance like this was developed in Hamburg, Germany, in 2003," Fink explains. "I heard about it on my trips there and was very intrigued because the European model of emergency medical service is different than the American model. In Europe, doctors often go out on the ambulances and they do more treatment in the field than we do."
With good results observed in Europe from use of the MSUs, Fink concluded that his center should offer this capability.
"We have worked very hard to initiate treatment of stroke as fast as possible, and we have done very well, but we have come to the point where we have done it as fast as we possibly can when patients [are brought] to the ED," he says. "The only way we can do it even faster is to do it in the field."
Initially, stakeholders were hesitant to approve the project because of all the rules, regulations, and bureaucracy, but Fink persisted in pushing the concept.
"I was convinced that this was really the next phase in treating patients with acute stroke because if we could cut down the time to treatment, it was going to result in saving lives and increasing the number of people making a full recovery," Fink notes. "To me, that was a really important goal."
The turning point came in 2015 when a hospital board member bought into the MSU approach, convinced others on the merits of the idea, and offered to underwrite the project. "Then we were off and running," Fink adds.
However, Fink notes that building the MSU and getting all the physicians on board with the innovation was the easy part. Much more difficult was the process of working through all the regulatory agencies and receiving appropriate approvals from both the state and the city.
"We had to integrate [the MSU approach] with the 911 EMS fire department system, which runs all of the ambulances in New York City," Fink explains. "We have the largest EMS system in the country."
Integrate with EMS
With all the approvals finally in hand, the MSU began deploying on Oct. 3, 2016 , in what is phase one of the project. During this period, a neurologist is on board the MSU along with two paramedics and a CT technologist. Also on board is a portable CT scanner that can image a patient's brain to determine if the patient is suffering a stroke.
When someone calls 911, the dispatcher will ask a few questions based on the Cincinnati Prehospital Stroke Scale. If the answers suggest that the probability of stroke is high, then the dispatcher will send both a basic life support unit and the MSU to the scene.
"We also monitor all the radio chatter on the EMS radio channel so if we hear of a case that we are not called for but we think it sounds like a stroke, then we will dispatch the stroke unit ourselves," Fink explains. R ecurrent cerebral vascular events (RCVEs) are one of the main determinants of outcome in patients after minor strokes and transient ischemic attacks (TIAs). The risk of recurrence is highest within 90 days and is particularly high in the first 48 hours. A number of scoring systems have been developed to attempt a prediction and stratify high-risk from low-risk patients. However, the scores have been limited because they were derived from mostly non-neurologist diagnosed TIA samples and their applicability to patients seen by current neurology stroke teams is questionable. The objective of this study is to determine predictors of early recurrent cerebral vascular events among patients with TIA or minor stroke, defined as an NIHSS of 0 to 3. This retrospective cohort study was conducted at two tertiary care centers, Columbia University in New York, and Tulane University in New Orleans, from 2010 until 2014. All patients were diagnosed with a TIA or minor stroke by a neurologist when they presented to the emergency department. The primary outcome was a recurrent neurological event unexplained by any other medical condition. Of 1,258 total patients, 71 had recurrent events. In a multivariate model of prediction for recurrent infarct, the significance predictors were 1) infarcts on neuroimaging (CT or diffusion-weighted MRI), with an odds ratio of 1.75, and 2) large vessel disease etiology, with an odds ratio of 6.69. When both predictors were present, there was a further increase in the risk of patients to have recurrent cerebral vascular events. When neither predictor was present, the rate of recurring events was extremely low (up to 2%). Patients who had recurrent events were less likely to be discharged to home. T he CHANCE study showed that the combination of aspirin and clopidogrel was superior to aspirin alone for reducing the risk of stroke in the first 90 days after a TIA or minor ischemic stroke (N Engl J Med 2013;369:11-19). In its 2014 guidelines, the American Heart Association recommended that the combination of aspirin and clopidogrel can be initiated within 24 hours for a minor ischemic stroke or TIA and continued for 90 days. However, the CHANCE trial was performed in China with a discrete ethnic population, and it was not clear if the optimal duration of treatment should be 90 days or longer. In ischemic heart disease, treatment with dual antiplatelet therapy beyond one year is the standard of care in patients who have coronary stents, and this question has been unanswered in patients with transient ischemic attack or stroke. Therefore, the authors performed a comprehensive literature review and meta-analysis, and identified nine randomized controlled trials that included 21,923 patients. In review of these trials, shortterm dual antiplatelet therapy significantly reduced the risk of ischemic stroke recurrence by 41% and major vascular events by 30%, without an increased risk of intracranial hemorrhage. Prolonged treatment beyond 90 days reduced the risk of ischemic stroke recurrence by 12% and major vascular events by 10%. However, the risk of major bleeding and intracranial hemorrhage was increased in those patients treated for a longer term. Therefore, it appears that shortterm dual antiplatelet therapy appears to be superior to prolonged treatment. However, this difference in outcome needs to be confirmed by further well-designed randomized clinical trials. 
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Message from the Editor:
This article is based on personal interactions as a participant at the International Stroke Conference in Houston, Feb. 22-24, 2017. All interpretations and opinions are exclusively those of the author.
General Anesthesia in Endovascular Reperfusion Stroke Trials
Bruce Campbell from the University of Calgary, representing the HERMES collaboration, presented the effect of general anesthesia on outcomes in five endovascular reperfusion stroke trials that were reported in 2015, using pooled data. A logistic regression model was developed and adjusted for variables, which included age, sex, stroke severity on the NIH stroke scale, time from symptom onset to randomization, baseline ASPECT score, baseline site of occlusion, and whether the patient received alteplase prior to undergoing endovascular treatment. About 25% of patients received general anesthesia, and there were no significant differences in the baseline characteristics between the two groups. tPA was administered in 88% of the general anesthesia group and about 80% of the group that did not receive general anesthesia. Functional outcome was shown to be significantly better (mRS 0-2) in the group that did not receive general anesthesia, with an odds ratio of 2.62 in favor of no anesthesia resulting in improved outcomes (statistically significant, P < 0.001). In patients who underwent thrombectomy, there was a 50% return to functional independence in those who were treated without general anesthesia, compared to only a 36% recovery to functional independence in those who were treated with general anesthesia. There was an improvement in terms of early recovery, return to normal function, and reduced mortality in patients who were treated with thrombectomy without general anesthesia, all statistically significant. In conclusion, neurological outcomes are better in patients who were treated without general anesthesia, and there were more complications associated with general anesthesia, particularly an increased risk of pneumonia.
CT Perfusion Imaging
In a second presentation, Bruce Campbell presented data from seven recent trials of endovascular therapy, which included pool data from 1,764 patients, using CT perfusion imaging to define the ischemic core volume and determine the relationship of ischemic core volume to functional outcome following endovascular thrombectomy. Ischemic core was calculated by a fully automated computerized system from Phillips imaging. The ischemic core was defined as a reduction of cerebral blood flow > 30% of blood flow to normal brain. The endovascular group and the control group were well matched for baseline characteristics, including median NIHSS of 17, initial median ASPECTS score of 8, percent that received alteplase, and baseline median ischemic core volume of 10 mL in the endovascular group and 9 mL in the control group. In the control group that received IV tPA, there was a rapid drop-off in functional independence (mRS 0-2) as the ischemic core volume increased, from 50% recovery when there was a core volume close to 0 down to 10% as the ischemic core approached 70 mL. With endovascular therapy, the curve shifted upward, showing 70% functional recovery with an ischemic core of 0, and as much as 30% functional recovery with an ischemic core of 70 mL, and a straight-line relationship between those two points. The differences between the two groups were highly significant after adjustment for all other variables. If full reperfusion was accomplished, the curve shifted upward again, and functional independent outcome improved a step further. In patients who had ischemic cores > 70 mL, there was no statistically significant benefit or difference between treatment with intravenous tPA compared to endovascular thrombectomy. In conclusion, ischemic core volume is correlated with worse outcome, and ischemic core volume > 70 mL does not seem to favor endovascular thrombectomy over intravenous thrombolysis.
Contact Aspiration of Intracranial Clot vs. Stent-retriever
Bertrand Lapergue, from Versailles, France, presented the results of the ASTER trial, comparing the addition of contact aspiration of intracranial clot vs. stent-retriever as the initial intervention for recanalization in patients with acute cerebral infarction. The investigators aimed to ascertain whether contact aspiration was more efficient as a 
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Rehabilitation is a critical component of stroke treatment, as most stroke survivors are left with significant neurological impairments and other sequelae, such as spasticity and pain. Approximately 40% of stroke patients are left with moderate functional impairment and 15%-30% with severe disability.
1 Stroke rehabilitation aims to reverse these impairments to the extent possible, maximize functionality through the use of compensatory approaches, prevent complications, and manage comorbidities. This article reviews the basic principles of rehabilitation, current practices, and evidence supporting various aspects of stroke rehabilitation.
Role of Primary Care Physician
With millions of stroke survivors in the United States, primary care physicians often are faced with providing care to these individuals and, thus, need to be able to identify common post-stroke rehabilitation issues. Post-stroke depression can occur at any time after stroke, and it is important that primary care physicians recognize this as a treatable and reversible condition, rather than a "natural" consequence of disability after stroke. Monitoring range of motion to identify developing contracture and/or spasticity is important so that referral can be made to a rehabilitation physician if these occur. Lastly, addressing the stroke survivor's mobility, ability to perform activities of daily living (ADL), and any deterioration in functional status are critical to making timely referrals to rehabilitation services when needed. When these issues are identified early, the primary care physician can prevent the progression of debilitating consequences by initiating treatment or referring to appropriate specialists for further evaluation and management.
Rehabilitation
Functional improvement in rehabilitation is accomplished through a combination of neurological recovery and adoption of compensatory techniques and equipment. Improved functional independence may be attained by reducing impairment directly (i.e., via neural recovery using cerebral plasticity to overcome neuronal loss) or through compensation for impairment by using remaining physical and cognitive abilities and strategies. Both recovery and compensation are crucial concepts in rehabilitation and key therapeutic approaches; interventions must be balanced to address patient goals and efficiently deploy the available rehabilitation resources. 2 Over the last several decades, a significant amount of research has been conducted to further elucidate how best to provide comprehensive stroke rehabilitation. Currently, it is comprised of several key components, including assessment, goal setting, treatment of functional and psychosocial impairments, and prevention of complications. Patients are reassessed at regular intervals to evaluate progress, and treatment plans are adjusted accordingly. Ideally, rehabilitation begins immediately following stroke and often becomes a long-term element in the lives of these patients. Assessment and treatment should begin in the setting of acute hospitalization, and depending on the needs of the individual, continued rehabilitation may transition to the appropriate inpatient or outpatient setting.
National and international guidelines have been developed to provide resources for health care providers with the latest evidence-based practices, such as the American Heart Association (AHA) Guidelines published in 2016. 3 The AHA grading system for level of evidence and strength of recommendation are referenced in this article where applicable. 3 (See Table 1 .) Adherence to stroke rehabilitation guidelines is associated with improved patient functional outcomes. 4 In an effort by the Joint Commission and the AHA, certification has been developed using current guidelines and established standards of care to identify both Primary Stroke Centers and Comprehensive Stroke Centers. The rehabilitation requirements for Primary Stroke Center certification include the ability to assess for rehabilitation needs and refer for appropriate post-acute care. Comprehensive Stroke Centers also must have a rehabilitation service led by a physician with expertise in neurorehabilitation, and the service must include therapists, nurses, and social workers with an expertise in addressing the rehabilitation needs of stroke patients. 5, 6 Complete guidelines can be found on the Joint Commission's website. Stroke: Rehabilitation and Recovery confirm this hypothesis for an upper limb exercise intervention.11 Overall, there is insufficient evidence to make specific recommendations regarding the optimal level of intensity of rehabilitation services. Determining intensity level as well as duration of therapy is often greatly impacted by the mental and physical tolerance of the patient to participate in therapy, and therefore, programs must be individualized based on the multidisciplinary team's assessment and plan of care.
Motor Rehabilitation
Many stroke patients suffer from muscle weakness and impaired motor control, with resultant functional deficits. Multiple therapeutic methods have been developed to aid stroke patients with improving motor function. These methods typically involve repeated practice of movements as a foundation, and vary greatly from simple task-specific training to more complex methods, using virtual reality or advanced robotics. Additional therapeutic options have emerged recently and are still currently being studied, including pharmacotherapy to facilitate plasticity and the use of non-invasive brain stimulation. (See Figure 1. ) Even if ultimately adopted, these novel therapies are likely to serve an adjunctive role to conventional physical and occupational therapy, rather than obviate the need for traditional forms of rehabilitation.
Conventional stroke rehabilitation includes repetitive task training; however, effects of specific interventions may generalize poorly to related tasks. Emphasis should be placed on task-or context-specific training, which has been found effective in improving upper and lower extremity motor function. 12 Constraint-induced movement therapy (CIMT) is another type of repetitive task training, involving forced use of the affected limb by "constraining" use of the non-paretic limb. A randomized trial found benefit in upper limb use after CIMT training, and it is considered a "reasonable" treatment for suitable stroke survivors (AHA Class IIa, Level of Evidence A). 13 The durability of this benefit is unknown, however, and additional research is required to define opti-
Figure 1. Transcranial Magnetic Stimulation
This technique is used both as a tool for investigating brain physiology during stroke recovery, and also as a potential therapy to enhance motor recovery.
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